Nisa Investment Advisors
RIGL icon

Nisa Investment Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

Nisa Investment Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.92K Hold
293
– – ﹤0.01% 2321
2025
Q4 		$12.5K Buy
293
+145
+98% +$5.47K ﹤0.01% 2131
2025
Q3 		$4.19K Hold
148
– – ﹤0.01% 2472
2025
Q2 		$2.77K Hold
148
– – ﹤0.01% 2542
2025
Q1 		$2.66K Hold
148
– – ﹤0.01% 2393
2024
Q4 		$2.49K Sell
148
-10
-6% -$192 ﹤0.01% 2421
2024
Q3 		$2.56K Sell
158
-147
-48% -$1.73K ﹤0.01% 2350
2024
Q2 		$2.51K Buy
305
+262
+609% +$2.74K ﹤0.01% 2353
2024
Q1 		$639 Buy
43
+29
+207% +$391 ﹤0.01% 2458
2023
Q4 		$196 Hold
14
– – ﹤0.01% 2560
2023
Q3 		$146 Sell
14
-2
-13% -$24 ﹤0.01% 2703
2023
Q2 		$210 Sell
16
-640
-98% -$8.65K ﹤0.01% 2698
2023
Q1 		$9K Buy
656
+640
+4,000% +$10.2K ﹤0.01% 2175
2022
Q4 		$0 Buy
+16
New +$147 ﹤0.01% 2692
2014
Q2 		– Sell
-1,460
Closed -$57K – 1325
2014
Q1 		$57K Buy
+1,460
New +$52K ﹤0.01% 1319

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nisa Investment Advisors's RIGL Position: Q1 2026 in Review

Nisa Investment Advisors held its Rigel Pharmaceuticals (RIGL) position steady in Q1 2026 at 293 shares worth $7.92K. The position accounts for ﹤0.01% of the portfolio, ranked #2321.

Nisa Investment Advisors first reported a position in RIGL in Q1 2014 and has held it in 15 quarters since. The position peaked at $57K in Q1 2014. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Nisa Investment Advisors held 293 shares of Rigel Pharmaceuticals worth $7.92K as of Q1 2026.
  • Nisa Investment Advisors left its Rigel Pharmaceuticals share count unchanged in Q1 2026.
  • Rigel Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2321 holding.
  • Nisa Investment Advisors first reported a position in Rigel Pharmaceuticals in Q1 2014 and has held it in 15 quarters since.
  • Nisa Investment Advisors's Rigel Pharmaceuticals position peaked at $57K in Q1 2014.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.